Wu S - Search Results

1

Design, synthesis, cytoselective toxicity, structure-activity relationships, and pharmacophore of thiazolidinone derivatives targeting drug-resistant lung cancer cells.

Zhou H, Wu S, Zhai S, Liu A, Sun Y, Li R, Zhang Y, Ekins S, Swaan PW, Fang B, Zhang B, Yan B. Zhou H, et al. Among authors: wu s. J Med Chem. 2008 Mar 13;51(5):1242-51. doi: 10.1021/jm7012024. Epub 2008 Feb 8. J Med Chem. 2008. PMID: 18257542

2

Analogues and derivatives of oncrasin-1, a novel inhibitor of the C-terminal domain of RNA polymerase II and their antitumor activities.

Wu S, Wang L, Guo W, Liu X, Liu J, Wei X, Fang B. Wu S, et al. J Med Chem. 2011 Apr 28;54(8):2668-79. doi: 10.1021/jm101417n. Epub 2011 Apr 6. J Med Chem. 2011. PMID: 21443218 Free PMC article.

3

Inhibiting JNK dephosphorylation and induction of apoptosis by novel anticancer agent NSC-741909 in cancer cells.

Wei X, Guo W, Wu S, Wang L, Lu Y, Xu B, Liu J, Fang B. Wei X, et al. Among authors: wu s. J Biol Chem. 2009 Jun 19;284(25):16948-16955. doi: 10.1074/jbc.M109.010256. Epub 2009 May 4. J Biol Chem. 2009. PMID: 19414586 Free PMC article.

4

Prodrug oncrasin-266 improves the stability, pharmacokinetics, and safety of NSC-743380.

Wu S, Wang L, Huang X, Cao M, Hu J, Li H, Zhang H, Sun X, Meng QH, Hofstetter WL, Roth JA, Swisher SG, Fang B. Wu S, et al. Bioorg Med Chem. 2014 Oct 1;22(19):5234-40. doi: 10.1016/j.bmc.2014.08.006. Epub 2014 Aug 14. Bioorg Med Chem. 2014. PMID: 25182964 Free PMC article.

5

P-glycoprotein-independent apoptosis induction by a novel synthetic compound, MMPT [5-[(4-methylphenyl)methylene]-2-(phenylamino)-4(5H)-thiazolone].

Teraishi F, Wu S, Sasaki J, Zhang L, Zhu HB, Davis JJ, Fang B. Teraishi F, et al. Among authors: wu s. J Pharmacol Exp Ther. 2005 Jul;314(1):355-62. doi: 10.1124/jpet.105.085654. Epub 2005 Apr 14. J Pharmacol Exp Ther. 2005. PMID: 15831436

6

Identification of a small molecule with synthetic lethality for K-ras and protein kinase C iota.

Guo W, Wu S, Liu J, Fang B. Guo W, et al. Among authors: wu s. Cancer Res. 2008 Sep 15;68(18):7403-8. doi: 10.1158/0008-5472.CAN-08-1449. Cancer Res. 2008. PMID: 18794128 Free PMC article.

7

Auranofin Enhances Ibrutinib's Anticancer Activity in EGFR-Mutant Lung Adenocarcinoma.

Hu J, Zhang H, Cao M, Wang L, Wu S, Fang B. Hu J, et al. Among authors: wu s. Mol Cancer Ther. 2018 Oct;17(10):2156-2163. doi: 10.1158/1535-7163.MCT-17-1173. Epub 2018 Jul 31. Mol Cancer Ther. 2018. PMID: 30065099

8

Expression of sulfotransferase SULT1A1 in cancer cells predicts susceptibility to the novel anticancer agent NSC-743380.

Huang X, Cao M, Wang L, Wu S, Liu X, Li H, Zhang H, Wang RY, Sun X, Wei C, Baggerly KA, Roth JA, Wang M, Swisher SG, Fang B. Huang X, et al. Among authors: wu s. Oncotarget. 2015 Jan 1;6(1):345-54. doi: 10.18632/oncotarget.2814. Oncotarget. 2015. PMID: 25514600 Free PMC article.

9

Induction of apoptosis and down-regulation of Bcl-XL in cancer cells by a novel small molecule, 2[[3-(2,3-dichlorophenoxy)propyl]amino]ethanol.

Wu S, Zhu H, Gu J, Zhang L, Teraishi F, Davis JJ, Jacob DA, Fang B. Wu S, et al. Cancer Res. 2004 Feb 1;64(3):1110-3. doi: 10.1158/0008-5472.can-03-2790. Cancer Res. 2004. PMID: 14871845

10

Development of small-molecule inhibitors of Raf.

Wu S, Guo W, Fang B. Wu S, et al. Recent Pat Antiinfect Drug Discov. 2006 Jun;1(2):241-6. doi: 10.2174/157489106777452665. Recent Pat Antiinfect Drug Discov. 2006. PMID: 18221149 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,493 results

Search Page

Filters